These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17989608

  • 1. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
    Imai A, Suzuki T, Sugitani A, Itoh T, Ueki S, Aoyagi T, Yamashita K, Taniguchi M, Takahashi N, Miura T, Shimamura T, Furukawa H, Todo S.
    Transplantation; 2007 Oct 27; 84(8):1020-8. PubMed ID: 17989608
    [Abstract] [Full Text] [Related]

  • 2. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.
    Aoyagi T, Yamashita K, Suzuki T, Uno M, Goto R, Taniguchi M, Shimamura T, Takahashi N, Miura T, Okimura K, Itoh T, Shimizu A, Furukawa H, Todo S.
    Am J Transplant; 2009 Aug 27; 9(8):1732-41. PubMed ID: 19519810
    [Abstract] [Full Text] [Related]

  • 3. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra KG, Ringers J, Sick EA, Ramdien-Murli S, Kuhn EM, Boon L, Jonker M.
    Transplantation; 2003 Mar 15; 75(5):637-43. PubMed ID: 12640302
    [Abstract] [Full Text] [Related]

  • 4. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG, Sick EA, Ringers J, Wubben JA, Kuhn EM, 't Hart BA, Boon L, Jonker M.
    Transplantation; 2006 Nov 15; 82(9):1194-201. PubMed ID: 17102771
    [Abstract] [Full Text] [Related]

  • 5. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP, Ossevoort M, Sick EA, Haanstra K, Jonker M.
    Transpl Immunol; 2003 Nov 15; 11(2):215-22. PubMed ID: 12799206
    [Abstract] [Full Text] [Related]

  • 6. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
    Yang H, Chen G, Kanai N, Shum J, Garcia B, Huang X, Min W, Luo Y, Dutartre P, Zhong R.
    Transplantation; 2003 Apr 27; 75(8):1166-71. PubMed ID: 12717197
    [Abstract] [Full Text] [Related]

  • 7. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons.
    Boulday G, Ashton-Chess J, Bernard P, Karam G, Vié H, Moreau A, Minault D, Lorré K, Soulillou JP, Blancho G.
    Nephrol Dial Transplant; 2004 Jul 27; 19(7):1752-60. PubMed ID: 15069178
    [Abstract] [Full Text] [Related]

  • 8. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
    Bîrsan T, Hausen B, Higgins JP, Hubble RW, Klupp J, Stalder M, Celniker A, Friedrich S, O'Hara RM, Morris RE.
    Transplantation; 2003 Jun 27; 75(12):2106-13. PubMed ID: 12829920
    [Abstract] [Full Text] [Related]

  • 9. Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms.
    Azimzadeh AM, Pfeiffer S, Wu G, Schröder C, Zorn GL, Kelishadi SS, Ozkaynak E, Kehry M, Atkinson JB, Miller GG, Pierson RN.
    Transplantation; 2006 Jan 27; 81(2):255-64. PubMed ID: 16436970
    [Abstract] [Full Text] [Related]

  • 10. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].
    Zhang J, Chen GH, Weng JP, Lu MQ, Yang Y, Cai CJ, Xu C, Li H.
    Zhonghua Wai Ke Za Zhi; 2008 Jan 15; 46(2):136-9. PubMed ID: 18509975
    [Abstract] [Full Text] [Related]

  • 11. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model.
    Jensen JN, Tung TH, Mackinnon SE, Brenner MJ, Hunter DA.
    Microsurgery; 2004 Jan 15; 24(4):309-15. PubMed ID: 15274190
    [Abstract] [Full Text] [Related]

  • 12. The role of a primate model of renal transplantation in the development of new monoclonal antibodies.
    Shapiro ME, Reed MH, Strom TB, Carpenter CB, Milford EL, Kirkman RL.
    Am J Kidney Dis; 1989 Nov 15; 14(5 Suppl 2):58-60. PubMed ID: 2816938
    [Abstract] [Full Text] [Related]

  • 13. The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge.
    Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, Garber EA, Hess DM, Shapiro RI, Kenyon NS, Harlan DM, Kirk AD, Burkly LC, Taylor FR.
    Int Immunol; 2004 Nov 15; 16(11):1583-94. PubMed ID: 15466914
    [Abstract] [Full Text] [Related]

  • 14. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.
    Maki T, Carville A, Stillman IE, Sato K, Kodaka T, Minamimura K, Ogawa N, Kanamoto A, Gottschalk R, Monaco AP, Marr-Belvin A, Westmoreland SV, Sehgal P.
    Transplantation; 2008 Mar 27; 85(6):893-902. PubMed ID: 18360273
    [Abstract] [Full Text] [Related]

  • 15. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS, Burkly LC, Fechner JH, Kirk AD, Oberley TD, Dong Y, Brunner KG, Peters D, Tenhoor CN, Nadeau K, Yagci G, Ishido N, Schultz JM, Tsuchida M, Hamawy MM, Knechtle SJ.
    Transplantation; 2001 Aug 27; 72(4):587-97. PubMed ID: 11544416
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H, Lu HM, Hu WM, Tian BL, Liu XB, Zhang ZD, Mai G.
    Transplant Proc; 2007 Dec 27; 39(10):3452-4. PubMed ID: 18089405
    [Abstract] [Full Text] [Related]

  • 17. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T, Liu Y, Jiang J, Wang H, Temple CL, Sun H, Garcia B, Zhong R, Ross DC.
    Transplantation; 2007 Dec 27; 84(12):1636-43. PubMed ID: 18165776
    [Abstract] [Full Text] [Related]

  • 18. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.
    Elster EA, Hale DA, Mannon RB, Cendales LC, Swanson SJ, Kirk AD.
    Transpl Immunol; 2004 Dec 27; 13(2):87-99. PubMed ID: 15380539
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W, Bigaud M, Brinkmann V, Di Padova F, Geisse S, Gram H, Hungerford V, Kleuser B, Kristofic C, Menninger K, Tees R, Wieczorek G, Wilt C, Wioland C, Zurini M.
    Transplantation; 2004 Mar 15; 77(5):717-26. PubMed ID: 15021835
    [Abstract] [Full Text] [Related]

  • 20. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats.
    Kumamoto Y, Tamura A, Volk HD, Reinke P, Löhler J, Tullius SG, Utku N.
    Transpl Immunol; 2006 Nov 15; 16(3-4):238-44. PubMed ID: 17138060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.